Aspira Pathlab & Diagnostics Limited (BOM: 540788)

Aspira Pathlab & Diagnostics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	639	319	287	667	293	356
Market Cap Growth	54.50%	11.31%	-57.02%	127.37%	-17.58%	150.60%
Enterprise Value	640	329	285	671	378	441
Last Close Price	62.10	31.00	27.85	64.80	28.50	38.30
PE Ratio	-	-	-	14.96	21.24	-
PS Ratio	-	2.42	1.98	3.41	1.93	4.23
PB Ratio	5.73	3.15	2.25	5.22	3.53	9.36
P/TBV Ratio	5.31	12.54	5.59	13.05	49.93	-
P/FCF Ratio	-	40.33	-	46.56	5.29	-
P/OCF Ratio	-	30.30	-	32.84	5.17	-
EV/Sales Ratio	-	2.49	1.97	3.43	2.49	5.24
EV/EBITDA Ratio	-	-	35.26	11.82	12.60	-
EV/EBIT Ratio	-	-	3700.96	14.17	18.29	-
EV/FCF Ratio	-	41.55	-	46.85	6.82	-
Debt / Equity Ratio	0.22	0.27	0.26	0.31	0.25	2.34
Debt / EBITDA Ratio	-	-	2.16	0.62	0.60	-
Debt / FCF Ratio	-	3.52	-	2.74	0.38	-
Asset Turnover	-	0.82	0.82	1.31	1.16	0.58
Inventory Turnover	-	23.14	22.06	24.80	27.54	26.44
Quick Ratio	2.21	1.76	2.97	3.44	1.44	0.26
Current Ratio	2.51	2.10	3.70	3.99	1.93	0.64
Return on Equity (ROE)	-	-23.34%	-0.69%	42.26%	22.80%	-94.32%
Return on Assets (ROA)	-	-10.63%	0.03%	19.80%	9.90%	-14.97%
Return on Capital (ROIC)	-	-11.75%	0.03%	21.84%	11.21%	-17.12%
Earnings Yield	-8.37%	-0.31%	6.69%	4.71%	-11.91%
FCF Yield	2.48%	-0.50%	2.15%	18.92%	-5.37%
Buyback Yield / Dilution	-4.50%	-	-	-8.12%	-11.07%	-22.58%
Total Shareholder Return	-4.50%	-	-	-8.12%	-11.07%	-22.58%

Source: S&P Capital IQ. Standard template. Financial Sources.